Kronos Bio Inc (KRON)
1.01
+0.03
(+2.87%)
USD |
NASDAQ |
May 17, 16:00
1.01
0.00 (0.00%)
After-Hours: 20:00
Kronos Bio Total Assets (Quarterly): 182.98M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 182.98M |
| December 31, 2023 | 213.28M |
| September 30, 2023 | 237.99M |
| June 30, 2023 | 260.62M |
| March 31, 2023 | 289.02M |
| December 31, 2022 | 294.94M |
| September 30, 2022 | 317.67M |
| June 30, 2022 | 341.22M |
| March 31, 2022 | 365.86M |
| Date | Value |
|---|---|
| December 31, 2021 | 391.48M |
| September 30, 2021 | 447.53M |
| June 30, 2021 | 471.74M |
| March 31, 2021 | 487.96M |
| December 31, 2020 | 511.96M |
| September 30, 2020 | 262.56M |
| June 30, 2020 | 120.53M |
| December 31, 2019 | 102.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
102.69M
Minimum
Dec 2019
511.96M
Maximum
Dec 2020
311.77M
Average
294.94M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Protalix BioTherapeutics Inc | 89.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.01M |
| Shareholders Equity (Quarterly) | 136.97M |
| Current Ratio | 8.321 |